Comparison of the VERSANT™ HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR™ hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy

Jeffrey J. Germer, Nizar N. Zein, Mohamed A. Metwally, Tanya L. Hoskin, W. Scott Harmsen, Thomas F. Smith, Robin Patel

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of the VERSANT™ HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR™ hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences